Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 27, 2007 02:46 ET | Source: Epigenomics AG

Epigenomics AG Demonstrates Feasibility of Convenient Blood Test for Lung Cancer Detection in Clinical Study

-- Positive clinical data from collaborative study with Charite -- Potential to address a high unmet medical need as no IVD test for lung cancer available thus far -- Successful clinical...
May 29, 2007 02:32 ET | Source: Epigenomics AG

QIAGEN and Epigenomics Expand Successful Partnership

BERLIN and VENLO, The Netherlands, May 29, 2007 (PRIME NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) (Prime Standard:QIA) and Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX) today...
May 29, 2007 02:30 ET | Source: Epigenomics AG

Ad Hoc: Epigenomics AG Expands Partnership With QIAGEN N.V.

BERLIN and SEATTLE, May 29, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) today announced that it further expanded the existing strategic partnership with QIAGEN N.V. (Nasdaq:QGEN)...
May 21, 2007 03:10 ET | Source: Epigenomics AG

New Clinical Data Further Support Applicability of Epigenomics' Lead Biomarker For Colorectal Cancer Screening

BERLIN and SEATTLE, May 21, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) and Prof. Dr. Matthias Ebert, Professor of Clinical and Molecular Gastroenterology at the University Hospital of the...
May 09, 2007 02:10 ET | Source: Epigenomics AG

Epigenomics AG Enters Into R&D Collaboration With Myriad Genetics Inc. to Discover DNA Methylation Biomarkers

BERLIN and SEATTLE, May 9, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing products based on DNA methylation, has entered into an R&D...
May 03, 2007 14:30 ET | Source: Epigenomics AG

Ad Hoc: Epigenomics AG Announces Capital Increase

BERLIN and SEATTLE, May 3, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) today announced that its Management Board and Supervisory Board decided to increase the company's share capital...
April 18, 2007 02:42 ET | Source: Epigenomics AG

Epigenomics AG: Significant Improvement in Colorectal Cancer Early Detection by DNA Methylation Test Through Modified Assay Procedure

BERLIN and SEATTLE, April 18, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing tests based on DNA methylation, yesterday presented the most...
April 13, 2007 02:48 ET | Source: Epigenomics AG

Epigenomics Optimizes Workflow for Testing its Proprietary Biomarkers for the Early Detection of Cancer in Blood Plasma

BERLIN and SEATTLE, April 13, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing tests based on DNA methylation, yesterday presented research...
April 12, 2007 08:18 ET | Source: Epigenomics AG

Clinical Data's Cogenics Division Enters Into Alliance With Epigenomics for DNA Methylation Services

NEWTON, Mass. and BERLIN, Germany, April 12, 2007 (PRIME NEWSWIRE) -- Clinical Data, Inc. (NASDAQ:CLDA) and Epigenomics AG (Other OTC:EPGNF) (FSE:ECX) today announced an agreement to offer...
April 11, 2007 02:58 ET | Source: Epigenomics AG

Epigenomics AG to Present Most Recent Data on Colorectal Cancer Screening at the Upcoming AACR Annual Meeting 2007

BERLIN and SEATTLE, April 11, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing tests based on DNA methylation, will present the most recent...